IGFBP5 and metabolic dysfunction-associated steatotic liver disease: However, in vitro studies of fatty liver disease using cultured hepatocytes fed with free fatty acids and in vivo studies maintaining mice on a high fat diet show that IGFBP5 is decreased in NAFLD models, and overexpression of IGFBP5 resulted in reduced expression of proteins associated with lipogenesis (50).